Clinical Social Workers in Ellisville, MO Accepting Medicare

4 Clinical Social Workers found. Showing 1 - 4

Mrs. Karla L Pollock-smith, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15620 Manchester Rd, Suite #30, Ellisville, MO 63011 Phone: 636-536-7709

Jessica P Fraser, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 119 Clarkson Executive Park, Ellisville, MO 63011 Phone: 636-256-0600

Judy Hillyer, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 210 Clarkson Executive Park, Ellisville, MO 63011 Phone: 636-295-6010

Sandra Brown Mckay, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 300 Ozark Trail Dr, Suite 226, Ellisville, MO 63011 Phone: 636-236-7894

News Archive

Blocking c-Abl enzyme prevents Parkinson's disease progression in mice

Researchers at Johns Hopkins say they have gleaned two important new clues in the fight against Parkinson's disease: that blocking an enzyme called c-Abl prevents the disease in specially bred mice, and that a chemical tag on a second protein may signal the disorder's presence and progression.

Past exposures influence immune response in children with acute respiratory tract infections

Acute respiratory tract infections (ARTI) are the leading global cause of death in early childhood, according to the Centers for Disease Control and Prevention.

Alzheimer's drug pioneer to be awarded Israel Prize for Medicine

Israel's Minister of Education Shai Piron has announced that the Israel Prize for Medicine will be awarded to the Hebrew University of Jerusalem's Prof. Marta Weinstock-Rosin. A professor emeritus at the Hebrew University's School of Pharmacy-Institute for Drug Research in the Faculty of Medicine, Weinstock-Rosin is best known for developing Exelon, a blockbuster drug for the treatment of confusion and dementia related to Alzheimer's and Parkinson's diseases.

StemCells seeks Swiss authorization to conduct human neural stem cells clinical trial in chronic spinal cord injury

StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.

Read more Medical News

› Verified 8 days ago